Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3463692

COc1cc(C(Nc2ccc(C(=N)N)cc2)C(=O)NNC(=O)c2ccccn2)cc(OC)c1OC.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F7 P08709 12/20 0.49
F10 P00742 10/20 0.49
F2 P00734 10/20 0.49
PRSS1 P07477 10/20 0.49
F3 P13726 5/20 0.48
PRSS2 P07478 3/20 0.48
PRSS3 P35030 3/20 0.48
SMN1; SMN2 Q16637 5/20 0.46
RAB9A P51151 3/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 2/20 0.42
LMNA P02545 3/20 0.41
HTT P42858 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
MITF O75030 1/20 0.41
TP53 P04637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NCOA3 Q9Y6Q9 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13162995 0.94 SMN1; SMN2 (0.52) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3463115 0.89 F7 (0.51) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3464263 0.89 F7 (0.53) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3463887 0.88 F7 (0.49) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3464880 0.88 F2 (0.43) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3463826 0.87 F7 (0.46) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3464517 0.87 F7 (0.48) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3463773 0.87 F2 (0.46) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3464084 0.86 F7 (0.47) F7F10F2PRSS1F3
Trifluoroacetic Acid SCHEMBL3463854 0.86 F7 (0.54) F7F10F2PRSS1F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240654-A1 HYDRAZIDE DERIVATIVES CLARK RICHARD 2010-09-23 US disclosed
US-20080132507-A1 Hydrazide Derivatives EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-06-05 US disclosed
EP-1810965-A1 HYDRAZIDE DERIVATIVES Eisai R&D Management Co., Ltd. (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240654-A1 HYDRAZIDE DERIVATIVES H1-10, H1-4, H1-3 F7 185/4885F10 11/4885F2 19/4885
US-20080132507-A1 Hydrazide Derivatives H1-10, H1-4, H1-3 F7 185/4885F10 11/4885F2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.